These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 26795113)
1. Design, synthesis and biological evaluation of novel analgesic agents targeting both cyclooxygenase and TRPV1. Yan L; Pan M; Fu M; Wang J; Huang W; Qian H Bioorg Med Chem; 2016 Feb; 24(4):849-57. PubMed ID: 26795113 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of anti-inflammatory and analgesic effects of synthesized derivatives of ibuprofen. Wang J; Dai D; Qiu Q; Deng X; Lin H; Qian H; Huang W Chem Biol Drug Des; 2015 May; 85(5):623-32. PubMed ID: 24618048 [TBL] [Abstract][Full Text] [Related]
3. Synthesis of Analogues of BCTC Incorporating a Pyrrolidinyl Linker and Biological Evaluation as Transient Receptor Potential Vanilloid 1 Antagonists. Yan L; Wang J; Pan M; Qiu Q; Huang W; Qian H Chem Biol Drug Des; 2016 Feb; 87(2):306-11. PubMed ID: 26360809 [TBL] [Abstract][Full Text] [Related]
4. Design and characterization of a noncompetitive antagonist of the transient receptor potential vanilloid subunit 1 channel with in vivo analgesic and anti-inflammatory activity. García-Martínez C; Fernández-Carvajal A; Valenzuela B; Gomis A; Van Den Nest W; Ferroni S; Carreño C; Belmonte C; Ferrer-Montiel A J Pain; 2006 Oct; 7(10):735-46. PubMed ID: 17018334 [TBL] [Abstract][Full Text] [Related]
5. Novel piperazine urea derivatives as highly potent transient receptor potential vanilloid 1 (TRPV1) antagonists. Hu J; Gao M; Zhang Y; Wang Y; Qiao Z; Zhang W; Wang Q; Yan L; Qian H Bioorg Chem; 2021 Oct; 115():105229. PubMed ID: 34364049 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of carbamide derivatives bearing tetrahydroisoquinoline moieties and biological evaluation as analgesia drugs in mice. Qiu Q; Wang J; Deng X; Qian H; Lin H; Huang W Arch Pharm (Weinheim); 2015 May; 348(5):347-52. PubMed ID: 25824579 [TBL] [Abstract][Full Text] [Related]
7. Novel phenylpiperazine derivatives as potent transient receptor potential vanilloid 1 antagonists. Jing L; Liu C Chem Biol Drug Des; 2024 Jul; 104(1):e14584. PubMed ID: 38997239 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of N Gao M; Nie C; Li J; Song B; Cheng X; Sun E; Yan L; Qian H Bioorg Chem; 2019 Feb; 82():100-108. PubMed ID: 30278281 [TBL] [Abstract][Full Text] [Related]
9. Pharmacology of modality-specific transient receptor potential vanilloid-1 antagonists that do not alter body temperature. Reilly RM; McDonald HA; Puttfarcken PS; Joshi SK; Lewis L; Pai M; Franklin PH; Segreti JA; Neelands TR; Han P; Chen J; Mantyh PW; Ghilardi JR; Turner TM; Voight EA; Daanen JF; Schmidt RG; Gomtsyan A; Kort ME; Faltynek CR; Kym PR J Pharmacol Exp Ther; 2012 Aug; 342(2):416-28. PubMed ID: 22570364 [TBL] [Abstract][Full Text] [Related]
10. Identification and biological evaluation of 4-(3-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonist. Swanson DM; Dubin AE; Shah C; Nasser N; Chang L; Dax SL; Jetter M; Breitenbucher JG; Liu C; Mazur C; Lord B; Gonzales L; Hoey K; Rizzolio M; Bogenstaetter M; Codd EE; Lee DH; Zhang SP; Chaplan SR; Carruthers NI J Med Chem; 2005 Mar; 48(6):1857-72. PubMed ID: 15771431 [TBL] [Abstract][Full Text] [Related]
11. Dopamides, vanillylamides, ethanolamides, and arachidonic acid amides of anti-inflammatory and analgesic drug substances as TRPV1 ligands. Sinning C; Watzer B; De Petrocellis L; Di Marzo V; Imming P ChemMedChem; 2008 Dec; 3(12):1956-64. PubMed ID: 19003845 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and preliminary biological evaluation of capsaicin derivatives as potential analgesic drugs. Qian H; Fu Z; Huang W; Zhang H; Zhou J; Ge L; Lin R; Lin H; Hu X Med Chem; 2010 Jul; 6(4):205-10. PubMed ID: 20843287 [TBL] [Abstract][Full Text] [Related]
13. 7-tert-Butyl-6-(4-chloro-phenyl)-2-thioxo-2,3-dihydro-1H-pyrido[2,3-d]pyrimidin-4-one, a classic polymodal inhibitor of transient receptor potential vanilloid type 1 with a reduced liability for hyperthermia, is analgesic and ameliorates visceral hypersensitivity. Nash MS; McIntyre P; Groarke A; Lilley E; Culshaw A; Hallett A; Panesar M; Fox A; Bevan S J Pharmacol Exp Ther; 2012 Aug; 342(2):389-98. PubMed ID: 22566669 [TBL] [Abstract][Full Text] [Related]
14. Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade. Gavva NR; Bannon AW; Hovland DN; Lehto SG; Klionsky L; Surapaneni S; Immke DC; Henley C; Arik L; Bak A; Davis J; Ernst N; Hever G; Kuang R; Shi L; Tamir R; Wang J; Wang W; Zajic G; Zhu D; Norman MH; Louis JC; Magal E; Treanor JJ J Pharmacol Exp Ther; 2007 Oct; 323(1):128-37. PubMed ID: 17652633 [TBL] [Abstract][Full Text] [Related]